Huang C S, Wang M, Shun C T, Liaw K Y
Department of Surgery, National Taiwan University Hospital, Taipei, ROC.
J Formos Med Assoc. 1995 Jul;94(7):423-7.
A series of 108 patients with surgically treated Graves' disease were analyzed retrospectively in an attempt to determine factors that could affect postoperative thyroid function. Univariate analysis showed that remnant size, resected thyroid weight, antithyroid microsomal antibody and antithyroglobulin antibody titers were all significantly related to the postoperative outcome. Remnant size outweighed the other factors in prediction of thyroid status following subtotal thyroidectomy. When all the potential prognostic factors were individually adjusted by remnant size, only the degree of lymphocytic infiltration and antithyroid microsomal antibody titer were significantly associated with the postoperative outcome. Within the range of optimal remnant size, the higher the antithyroid microsomal antibody titer and the degree of lymphocytic infiltration, the greater the likelihood of postoperative hypothyroidism and the lower the chance of recurrence. Further stepwise discriminant analysis revealed that remnant size can be planned according to the known preoperative antithyroid microsomal antibody titer to achieve the greatest likelihood of a postoperative euthyroid state. The model suggested that when the antibody titer is < or = 640, the remnant size should be 3 to 5 cm3; if the antibody titer is 1,280 to 2,560, then the remnant size should be 4 to 5 cm3; and if the antibody titer is > or = 5,120, then the remnant size should be around 5 cm3.
对108例接受手术治疗的格雷夫斯病患者进行回顾性分析,以确定可能影响术后甲状腺功能的因素。单因素分析显示,残余甲状腺大小、切除的甲状腺重量、抗甲状腺微粒体抗体和抗甲状腺球蛋白抗体滴度均与术后结果显著相关。在预测甲状腺次全切除术后的甲状腺状态方面,残余甲状腺大小比其他因素更为重要。当所有潜在的预后因素根据残余甲状腺大小进行单独调整时,只有淋巴细胞浸润程度和抗甲状腺微粒体抗体滴度与术后结果显著相关。在最佳残余甲状腺大小范围内,抗甲状腺微粒体抗体滴度和淋巴细胞浸润程度越高,术后发生甲状腺功能减退的可能性越大,复发的机会越低。进一步的逐步判别分析显示,可根据术前已知的抗甲状腺微粒体抗体滴度来规划残余甲状腺大小,以实现术后甲状腺功能正常状态的最大可能性。该模型表明,当抗体滴度≤640时,残余甲状腺大小应为3至5立方厘米;如果抗体滴度为1280至2560,则残余甲状腺大小应为4至5立方厘米;如果抗体滴度≥5120,则残余甲状腺大小应为5立方厘米左右。